Fort Collins, Colorado Clinical Trials

A listing of Fort Collins, Colorado clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 57 clinical trials
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA) (DEBRA)

This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.

Poudre Valley Hospital
 (1.6 away) Contact site
  • 0 views
  • 22 Jul, 2022
  • +385 other locations
De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer

This phase II/III trial studies how well a reduced dose of radiation therapy works with nivolumab compared to cisplatin in treating patients with human papillomavirus (HPV)-positive oropharyngeal cancer that is early in its growth and may not have spread to other parts of the body (early-stage), and is not associated …

hepatitis b virus surface antigen
administration intravenous
primary tumor
pet-ct scan
tonsillectomy
Cancer Care and Hematology-Fort Collins
 (7.5 away) Contact site
  • 196 views
  • 21 Jul, 2022
  • +226 other locations
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer

This phase III trial studies how well the combination of pembrolizumab, paclitaxel and carboplatin works compared with paclitaxel and carboplatin alone in treating patients with endometrial cancer that is stage III or IV, or has come back (recurrent). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune …

thyroid stimulating hormone
recurrent endometrial cancer
serous adenocarcinoma
clear cell adenocarcinoma
absolute neutrophil count
Cancer Care and Hematology-Fort Collins
 (7.5 away) Contact site
  • 198 views
  • 21 Jul, 2022
  • +181 other locations
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and …

gemcitabine
pemetrexed
paclitaxel
carcinoma
neutrophil count
Cancer Care and Hematology-Fort Collins
 (8.1 away) Contact site
  • 136 views
  • 25 Jul, 2022
  • +467 other locations
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer (TAILOR RT)

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming …

metastasis
mastectomy
adjuvant chemotherapy
sentinel lymph node biopsy
invasive carcinoma
Poudre Valley Hospital
 (1.6 away) Contact site
  • 760 views
  • 27 Jul, 2022
  • +325 other locations
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)

This is a randomized, double blind, controlled, parallel group, multicenter study to evaluate efficacy, safety and pharmacokinetics of a higher dose of ocrelizumab per intravenous (IV) infusion every 24 weeks in participants with PPMS, in comparison to the approved 600 mg dose of ocrelizumab.

oligoclonal bands
ocrelizumab
brain mri
methylprednisolone
disease or disorder
Advanced Neurosciences Research LLC
 (7.5 away) Contact site
  • 3 views
  • 27 Jul, 2022
  • +152 other locations
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery (either in the breast or underarm lymph nodes) after pre-operative chemotherapy and HER2-targeted therapy. Drugs used in chemotherapy, such …

mastectomy
progesterone receptor
tumor cells
chemotherapy drug
estrogen receptor
Cancer Care and Hematology-Fort Collins
 (8.1 away) Contact site
  • 92 views
  • 27 Jul, 2022
  • +639 other locations
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

lung cancer
metastasis
adjuvant chemotherapy
tumor cells
pemetrexed
Cancer Care and Hematology-Fort Collins
 (8.1 away) Contact site
  • 1154 views
  • 08 Aug, 2022
  • +1028 other locations
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

This phase III trial studies whether pembrolizumab alone as a first-line treatment, followed by pemetrexed and carboplatin with or without pembrolizumab after disease progression is superior to induction with pembrolizumab, pemetrexed and carboplatin followed by pembrolizumab and pemetrexed maintenance in treating patients with stage IV non-squamous non-small cell lung cancer. …

adjuvant therapy
corticosteroids
oophorectomy
immunodeficiency
tumor cells
Cancer Care and Hematology-Fort Collins
 (8.1 away) Contact site
  • 322 views
  • 09 Aug, 2022
  • +769 other locations
A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment (MagnetisMM-9)

The purpose of this study is to evaluate the safety of a step-up dosing approach (starting with low doses followed by higher doses) of the study medicine (elranatamab) in participants with multiple myeloma that has come back after responding to treatment or has not responded to treatment (relapsed/refractory multiple myeloma). …

refractory multiple myeloma
Poudre Valley Hospital
 (1.6 away) Contact site
  • 0 views
  • 08 Aug, 2022
  • +28 other locations